11.74
price down icon5.13%   -0.635
pre-market  Pre-mercato:  11.94   0.20   +1.70%
loading
Precedente Chiudi:
$12.38
Aprire:
$12.27
Volume 24 ore:
955.03K
Relative Volume:
2.33
Capitalizzazione di mercato:
$692.04M
Reddito:
$217.25M
Utile/perdita netta:
$-50.92M
Rapporto P/E:
-11.74
EPS:
-1
Flusso di cassa netto:
$-100.85M
1 W Prestazione:
-7.19%
1M Prestazione:
-25.74%
6M Prestazione:
-29.49%
1 anno Prestazione:
-55.11%
Intervallo 1D:
Value
$11.42
$12.45
Intervallo di 1 settimana:
Value
$11.42
$13.52
Portata 52W:
Value
$11.42
$25.42

Prothena Corporation Plc Stock (PRTA) Company Profile

Name
Nome
Prothena Corporation Plc
Name
Telefono
011-353-1-236-2500
Name
Indirizzo
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Name
Dipendente
0
Name
Cinguettio
@ProthenaCorp
Name
Prossima data di guadagno
2025-02-18
Name
Ultimi documenti SEC
Name
PRTA's Discussions on Twitter

Confronta PRTA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PRTA
Prothena Corporation Plc
11.74 692.04M 217.25M -50.92M -100.85M -1.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-20 Iniziato Chardan Capital Markets Buy
2024-01-30 Downgrade BofA Securities Buy → Neutral
2023-12-12 Iniziato Deutsche Bank Buy
2023-04-24 Iniziato SVB Securities Outperform
2023-01-27 Iniziato Piper Sandler Overweight
2022-11-04 Downgrade RBC Capital Mkts Outperform → Sector Perform
2022-09-28 Aggiornamento BofA Securities Neutral → Buy
2021-11-19 Iniziato JMP Securities Mkt Outperform
2021-06-18 Aggiornamento BofA Securities Underperform → Neutral
2021-06-08 Reiterato Oppenheimer Outperform
2021-05-26 Iniziato Citigroup Buy
2021-02-26 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2021-02-12 Aggiornamento Jefferies Hold → Buy
2021-02-02 Aggiornamento BTIG Research Neutral → Buy
2020-12-07 Iniziato H.C. Wainwright Buy
2020-07-09 Aggiornamento Oppenheimer Perform → Outperform
2019-11-19 Aggiornamento Evercore ISI In-line → Outperform
2018-05-21 Downgrade Barclays Equal Weight → Underweight
2018-04-23 Downgrade Jefferies Buy → Hold
2018-04-05 Reiterato Barclays Overweight
2017-11-20 Downgrade Wedbush Outperform → Neutral
2017-09-29 Reiterato BTIG Research Buy
2017-09-15 Iniziato RBC Capital Mkts Outperform
2017-08-17 Iniziato Evercore ISI Outperform
2017-07-11 Iniziato Jefferies Buy
2017-04-12 Iniziato Cantor Fitzgerald Overweight
2017-04-12 Iniziato Piper Jaffray Overweight
2017-03-02 Iniziato Instinet Buy
2016-12-21 Iniziato SunTrust Buy
2016-11-03 Iniziato Deutsche Bank Buy
2016-08-04 Reiterato Barclays Overweight
2016-05-13 Iniziato Barclays Overweight
2016-02-19 Reiterato Wedbush Outperform
2016-01-21 Iniziato Credit Suisse Outperform
Mostra tutto

Prothena Corporation Plc Borsa (PRTA) Ultime notizie

pulisher
Mar 26, 2025

Prothena Co. plc (NASDAQ:PRTA) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World

Mar 26, 2025
pulisher
Mar 23, 2025

Amundi Has $28,000 Stock Holdings in Prothena Co. plc (NASDAQ:PRTA) - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

(PRTA) Technical Data - news.stocktradersdaily.com

Mar 22, 2025
pulisher
Mar 22, 2025

Bank of New York Mellon Corp Has $2.08 Million Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World

Mar 22, 2025
pulisher
Mar 20, 2025

Brokerages Set Prothena Co. plc (NASDAQ:PRTA) Target Price at $55.00 - Defense World

Mar 20, 2025
pulisher
Mar 17, 2025

Zacks Research Has Positive Outlook of Prothena Q1 Earnings - Defense World

Mar 17, 2025
pulisher
Mar 16, 2025

Insider Sell: Chief Medical Officer Hideki Garren Sells 2,000 Sh - GuruFocus.com

Mar 16, 2025
pulisher
Mar 15, 2025

Zacks Research Weighs in on Prothena FY2027 Earnings - Defense World

Mar 15, 2025
pulisher
Mar 12, 2025

Trend Tracker for (PRTA) - Stock Traders Daily

Mar 12, 2025
pulisher
Mar 11, 2025

Recent Analysts’ Ratings Changes for Prothena (PRTA) - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

Rhumbline Advisers Boosts Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World

Mar 07, 2025
pulisher
Mar 04, 2025

Prothena Co. plc (NASDAQ:PRTA) Shares Purchased by Handelsbanken Fonder AB - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

Prothena Corporation: Multiple Failures Make It Risky (NASDAQ:PRTA) - Seeking Alpha

Mar 03, 2025
pulisher
Feb 28, 2025

Prothena (NASDAQ:PRTA) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

PROTHENA CORP PUBLIC LTD CO SEC 10-K Report - TradingView

Feb 27, 2025
pulisher
Feb 25, 2025

Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus - MSN

Feb 25, 2025
pulisher
Feb 25, 2025

Prothena's SWOT analysis: neurodegenerative disease pipeline drives stock potential By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Prothena's SWOT analysis: neurodegenerative disease pipeline drives stock potential - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

Prothena (NASDAQ:PRTA) Rating Increased to Hold at StockNews.com - Defense World

Feb 25, 2025
pulisher
Feb 24, 2025

Prothena Corp Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) - Benzinga

Feb 24, 2025
pulisher
Feb 24, 2025

Prothena’s (PRTA) “Buy” Rating Reiterated at HC Wainwright - Defense World

Feb 24, 2025
pulisher
Feb 24, 2025

Prothena’s (PRTA) “Buy” Rating Reiterated at Chardan Capital - Defense World

Feb 24, 2025
pulisher
Feb 23, 2025

Analysts Set Prothena Co. plc (NASDAQ:PRTA) PT at $46.50 - Defense World

Feb 23, 2025
pulisher
Feb 23, 2025

Cantor Fitzgerald Reaffirms “Overweight” Rating for Prothena (NASDAQ:PRTA) - Defense World

Feb 23, 2025
pulisher
Feb 23, 2025

Royal Bank of Canada Has Lowered Expectations for Prothena (NASDAQ:PRTA) Stock Price - Defense World

Feb 23, 2025
pulisher
Feb 22, 2025

Prothena Corporation plc (NASDAQ:PRTA) Just Released Its Yearly Earnings: Here's What Analysts Think - Simply Wall St

Feb 22, 2025
pulisher
Feb 21, 2025

Prothena Corporation plc (NASDAQ:PRTA) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 21, 2025
pulisher
Feb 21, 2025

RBC Cuts Price Target on Prothena to $20 From $24, Keeps Sector Perform, Speculative Risk - Marketscreener.com

Feb 21, 2025
pulisher
Feb 21, 2025

Prothena Corporation (NASDAQ: PRTA) Gears Up for Transformational 2025 with Key Clinical Milestones - Pradesh Tak

Feb 21, 2025
pulisher
Feb 21, 2025

Earnings call transcript: Prothena's Q4 2024 results highlight innovation By Investing.com - Investing.com Australia

Feb 21, 2025
pulisher
Feb 21, 2025

Prothena Corp PLC (PRTA) Q4 2024 Earnings Call Highlights: Strong Financial Position Amidst ... - Yahoo Finance

Feb 21, 2025
pulisher
Feb 20, 2025

Earnings call transcript: Prothena's Q4 2024 results highlight innovation - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

Prothena: Q4 Earnings Snapshot -February 20, 2025 at 04:23 pm EST - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights - Business Wire

Feb 20, 2025
pulisher
Feb 18, 2025

(PRTA) Trading Advice - Stock Traders Daily

Feb 18, 2025
pulisher
Feb 18, 2025

Prothena Corporation PLC expected to post a loss of $1.04 a shareEarnings Preview - TradingView

Feb 18, 2025
pulisher
Feb 17, 2025

Kuehn Law Encourages Investors of Prothena Corporation PLC to Contact Law Firm - EIN News

Feb 17, 2025
pulisher
Feb 17, 2025

The Prothena Corporation plc (PRTA) had a good session last reading, didn’t it? - US Post News

Feb 17, 2025
pulisher
Feb 17, 2025

Merck KGaA bids for SpringWorks (SWTX), Evolus (EOLS) receives FDA nod & Prothena (PRTA) struggles - substack.com

Feb 17, 2025
pulisher
Feb 13, 2025

Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 - Business Wire

Feb 13, 2025
pulisher
Feb 13, 2025

Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight - GlobeNewswire Inc.

Feb 13, 2025
pulisher
Feb 13, 2025

Focused Wealth Management Inc Makes New Investment in Prothena Co. plc (NASDAQ:PRTA) - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

Critical Survey: Prothena (NASDAQ:PRTA) vs. Annexon (NASDAQ:ANNX) - Defense World

Feb 13, 2025
pulisher
Feb 13, 2025

Prothena (PRTA) to Release Quarterly Earnings on Thursday - Defense World

Feb 13, 2025
pulisher
Feb 12, 2025

Prothena (NASDAQ:PRTA) Given New $62.00 Price Target at Oppenheimer - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

KALA BIO (NASDAQ:KALA) and Prothena (NASDAQ:PRTA) Financial Survey - Defense World

Feb 12, 2025
pulisher
Feb 10, 2025

Prothena (NASDAQ:PRTA) Price Target Raised to $62.00 - Defense World

Feb 10, 2025
pulisher
Feb 08, 2025

Form S-8Securities to be offered to employees in employee benefit plans - br.ADVFN.com

Feb 08, 2025
pulisher
Feb 08, 2025

Learn to Evaluate (PRTA) using the Charts - Stock Traders Daily

Feb 08, 2025
pulisher
Feb 07, 2025

Deep Dive Into Prothena Corp Stock: Analyst Perspectives (5 Ratings) - Benzinga

Feb 07, 2025

Prothena Corporation Plc Azioni (PRTA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
Capitalizzazione:     |  Volume (24 ore):